1Henter J I,Home A,Arico M. HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J].Pediatric Blood & Cancer,2007,(02):124-131.
5Wong C K,Wong B C,Chan K C. Cytokine profile in fatal human immunodeficiency virus tuberculosis Epstein-Barr virus associated hemophagocytic syndrome[J].Archives of Internal Medicine,2007,(17):1901-1903.doi:10.1001/archinte.167.17.1901.
6ISHII E,OHGA S,TANIMURA M,et al.Clinical and epidemiologic studies of familial hemophagocytic lymphohistiocytosis in Japan.Japan LCH Study Group[J].Med Pediatr Oncol,1998,30:276-283.
7ISHII E,OHGA S,IMASHUKU S,et al.Nationwide survey of hemophagocytic lymphohistiocytosis in Japan[J].Int J Hematol,2007,86:58-65.
8HENTER J,HORNE A,ARICO M,et al.HLH-2004:Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis[J].Pediatr Blood Cancer,2007,48:124-131.
10IMASHUKU S,KURIYAMA K,TERAMURA T,et al.Requirement for etoposide in the treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis[J].J Clin Oncol,2001,19:2665-2673.
